Concourse Financial Group Securities, Inc. Codex Dna, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share
Q1 2024 Apr 30, 2024	BUY	N/A
Q4 2023 Feb 07, 2024	BUY	N/A
Q3 2023 Oct 30, 2023	BUY	N/A
Q3 2023 Oct 25, 2023	BUY	N/A
Q2 2023 Aug 10, 2023	BUY	N/A
Q1 2023 May 15, 2023	BUY	$1.3 - $2.15 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$1.12 - $1.69 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.7 - $2.36 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.8 - $6.45 $0 - $0
Q1 2022 May 09, 2022	BUY	$4.12 - $10.36 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$6.31 - $11.96 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$10.15 - $19.88 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$17.76 - $22.0 $0 - $0

Others Institutions Holding DNAY

# of Institutions

Shares Held

307

Call Options Held

Put Options Held

First Capital Advisors Group, Llc. Little Silver, NJ

307
Shares

$567
0.0% of portfolio

View Full List

About Codex DNA, Inc.

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

More about DNAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account